13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-16, with 25 holding rows worth $219,699,000.
- Accession
- 0001140361-15-041435
- Filer
- CIK 1587114
- Filed
- 2015-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2015
A holdings report, 25 entries on the cover page, a total value of $219,699,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $219,698,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FIBROGEN INC | 31572Q808 | COM | 1,230,391 | $26,970,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 803,458 | $25,261,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 22,534,000 | $22,210,000 | thousands by filing date | principal |
| RETROPHIN INC | 761299106 | COM | 1,007,660 | $20,415,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 1,492,700 | $19,196,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,887,069 | $18,040,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 281,400 | $15,668,000 | thousands by filing date | |
| FLEX PHARMA INC | 33938A105 | COM | 933,691 | $11,214,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 465,118 | $10,284,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 840,462 | $8,623,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 835,530 | $7,938,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 1,323,431 | $6,882,000 | thousands by filing date | |
| GENVEC INC NEW | 37246C307 | cs | 1,986,413 | $4,589,000 | thousands by filing date | |
| CELLADON CORP | 15117E107 | Cmn | 2,843,170 | $2,985,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 943,500 | $2,585,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 100,709 | $2,417,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 101,995 | $2,403,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 149,000 | $2,293,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 415,480 | $2,256,000 | thousands by filing date | |
| GILEAD SCIENCES INC | 375558903 | COM | 3,255 | $2,148,000 | thousands by filing date | call |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 937,958 | $1,979,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 638,900 | $1,699,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTE | 91911K902 | COM | 1,265 | $1,347,000 | thousands by filing date | call |
| CATALYST | 14888D109 | COM | 56,000 | $261,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K901 | CALL | 1,280 | $35,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-15-041435 | this filing | 2015-11-16 | acceptance time not in the bulk data set |